Your browser doesn't support javascript.
loading
Validation of epidermal AMBRA1 and loricrin (AMBLor) as a prognostic biomarker for nonulcerated American Joint Committee on Cancer stage I/II cutaneous melanoma.
Ewen, Tom; Husain, Akhtar; Stefanos, Niki; Barrett, Paul; Jones, Claire; Ness, Tom; Long, Anna; Horswell, Stuart; Bosomworth, Helen; Lowenstein, Joe; Richardson, Grant; Swan, David; McConnell, Ashleigh; Rose, Aidan; Andrew, Tom; Reynolds, Nick; Malvehy, Josep; Carrera, Christina; Alos, Llucia; Mailer, Sonia; Helm, Thomas; Ding, Liang; Bogner, Paul; Podlipnik, Sebastian; Puig, Susana; McArthur, Grant A; Paragh, Gyorgy; Labus, Marie; Sloan, Philip; Armstrong, Jane L; Lovat, Penny E.
Affiliation
  • Ewen T; Translation and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Husain A; Novo Path and Cellular Pathology.
  • Stefanos N; Pathology, Addenbrookes Hospital, Cambridge University NHS Trust, Cambridge, UK.
  • Barrett P; Pathology, University Hospitals of North Durham, Durham, UK.
  • Jones C; Novo Path and Cellular Pathology.
  • Ness T; Novo Path and Cellular Pathology.
  • Long A; Novo Path and Cellular Pathology.
  • Horswell S; Translation and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Bosomworth H; Francis Crick Institute, London, UK.
  • Lowenstein J; Translation and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Richardson G; Translation and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Swan D; AMLo Biosciences, Newcastle upon Tyne, UK.
  • McConnell A; Translation and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Rose A; AMLo Biosciences, Newcastle upon Tyne, UK.
  • Andrew T; AMLo Biosciences, Newcastle upon Tyne, UK.
  • Reynolds N; Faculty of Health Sciences and Wellbeing, University of Sunderland, Sunderland, UK.
  • Malvehy J; Translation and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Carrera C; AMLo Biosciences, Newcastle upon Tyne, UK.
  • Alos L; Translation and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Mailer S; Translation and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Helm T; Translation and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Ding L; Department of Dermatology and NIHR Newcastle Biomedical Research Centre, Royal Victoria Infirmary, Newcastle upon Tyne, UK.
  • Bogner P; Hospital Clinic Barcelona, University of Barcelona, Barcelona, Spain.
  • Podlipnik S; Hospital Clinic Barcelona, University of Barcelona, Barcelona, Spain.
  • Puig S; Hospital Clinic Barcelona, University of Barcelona, Barcelona, Spain.
  • McArthur GA; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.
  • Paragh G; Division of Dermatology, Buffalo Medical Group, Williamsville, NY, USA.
  • Labus M; Department of Dermatology, Penn State Hershey, Hershey, Pennsylvania, USA.
  • Sloan P; Department of Pathology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Armstrong JL; Department of Pathology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Lovat PE; Department of Dermatology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Br J Dermatol ; 190(4): 549-558, 2024 Mar 15.
Article in En | MEDLINE | ID: mdl-38006317

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Melanoma / Membrane Proteins Limits: Humans Country/Region as subject: America do norte Language: En Journal: Br J Dermatol Year: 2024 Document type: Article Affiliation country: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Melanoma / Membrane Proteins Limits: Humans Country/Region as subject: America do norte Language: En Journal: Br J Dermatol Year: 2024 Document type: Article Affiliation country: Reino Unido